<p>Teladoc Health, Inc.（纽约证券交易所代码：TDOC - 获取免费报告）在周二的期权交易活动中出现了异常大的交易量。交易者购买了 26,725 份看涨期权。这比平均每日交易量 14,793 份看涨期权增加了 81%。</p>
<p>获取 <strong>Teladoc Health</strong> 的提醒：</p>
<h2>内部买卖</h2>
<ul>
<li>Peloton 股票正在上涨，但它能否再提供 70% 的上涨空间？</li>
</ul>
<p>在其他 Teladoc Health 的新闻中，首席执行官 Charles Divita III 于 3 月 11 日（星期三）出售了 27,731 股公司的股票。股票以平均价格 5.49 美元出售，总价值为 152,243.19 美元。出售完成后，首席执行官直接持有 364,784 股公司的股票，价值为 2,002,664.16 美元。此次交易使其持股减少了 7.06%。该交易在向美国证券交易委员会的法律文件中披露，文件可通过此链接获取。公司内部人士持有 0.70% 的股票。</p>
<h2>Teladoc Health 的机构交易</h2>
<p>一些大型投资者最近对 TDOC 的持仓进行了调整。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 Teladoc Health 的持仓增加了 2.8%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前持有 193,714 股该健康服务提供商的股票，价值为 1,542,000 美元，此前在上个季度又购买了 5,235 股。NewEdge Advisors LLC 在第一季度将其在 Teladoc Health 的持仓增加了 1,278.7%。NewEdge Advisors LLC 目前持有 11,305 股该健康服务提供商的股票，价值为 90,000 美元，此前在上个季度又购买了 10,485 股。瑞银资产管理公司（UBS AM）旗下的一个独立业务单位在第一季度将其在 Teladoc Health 的持仓增加了 5.7%。瑞银资产管理公司（UBS AM）目前持有 447,992 股该健康服务提供商的股票，价值为 3,566,000 美元，此前在上个季度又购买了 24,124 股。Acadian Asset Management LLC 在第一季度购买了 Teladoc Health 的新头寸，价值约为 615,000 美元。最后，Envestnet Asset Management Inc. 在第二季度购买了 Teladoc Health 的新头寸，价值约为 89,000 美元。机构投资者持有公司 76.82% 的股票。</p>
<h2>Teladoc Health 股票上涨 4.6%</h2>
<ul>
<li>2 只可能受益于特朗普新任 FDA 官员的远程医疗股票</li>
</ul>
<p>周二，TDOC 股票在交易时段上涨了 0.30 美元，达到 6.65 美元。该公司的交易量为 1,912,227 股，而其平均交易量为 5,878,010 股。该公司的 50 日移动平均线为 5.75 美元，200 日移动平均线为 6.29 美元。公司的债务与股本比率为 0.75，流动比率为 2.80，速动比率为 2.72。该公司的市值为 12 亿美元，市盈率为-6.83，贝塔值为 2.08。Teladoc Health 的一年低点为 4.40 美元，一年高点为 9.77 美元。</p>
<p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最近于 4 月 29 日（星期三）发布了季度财报。该健康服务提供商报告每股收益为（0.36 美元），低于分析师一致预期的（0.35 美元），差距为（0.01 美元）。Teladoc Health 的净利润率为-6.81%，股本回报率为-11.45%。该公司在本季度的收入为 6.1385 亿美元，而分析师预期为 6.1104 亿美元。去年同期，该公司每股收益为（0.53 美元）。该公司的季度收入较去年同期下降了 2.5%。Teladoc Health 将其 2026 财年的指导目标设定为每股收益-1.050 至-0.750 美元，2026 年第二季度的指导目标为每股收益-0.300 至-0.200 美元。平均而言，股票研究分析师预计 Teladoc Health 在当前年度的每股收益为-0.92 美元。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>2 只曾经的疫情明星股票瞄准 2025 年的大反弹</li>
</ul>
<p>一些券商对 TDOC 进行了评估。巴克莱在 3 月 26 日的研究报告中将 Teladoc Health 的目标价从 8.50 美元下调至 7.00 美元，并对该公司给予了 “持平” 评级。BMO Capital Markets 在 2 月 26 日的研究报告中将 Teladoc Health 的目标价从 8.00 美元下调至 5.00 美元，并对该股票给予了 “市场表现” 评级。Weiss Ratings 在 3 月 27 日的报告中重申了对 Teladoc Health 股票的 “卖出（e+）” 评级。花旗集团在 5 月 5 日的研究报告中将 Teladoc Health 的目标价从 6.00 美元上调至 7.00 美元，并对该股票给予了 “中性” 评级。最后，Leerink Partners 在 2 月 26 日的报告中将 Teladoc Health 的目标价从 8.50 美元下调至 5.50 美元，并对该股票给予了 “市场表现” 评级。五位研究分析师对该股票给予了买入评级，十二位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，该公司目前的平均评级为 “持有”，平均目标价为 7.53 美元。</p>
<p><strong>获取我们对 TDOC 的最新分析</strong></p>
<h2>Teladoc Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Teladoc Health, Inc 是全球领先的虚拟医疗服务提供商，通过电话、视频和移动应用平台提供按需医疗咨询。该公司将患者与持牌医生和专家连接，以解决非紧急医疗问题、心理健康支持、皮肤病和慢性病管理。通过利用数字技术和数据分析，Teladoc 旨在提高可及性、降低医疗成本，并通过个性化护理计划和远程监测改善患者结果。</p>
<p>Teladoc 的服务组合包括普通医疗访问、行为健康会话、复杂病例的专家医疗服务，以及旨在支持慢性病管理（如糖尿病、高血压和心脏病）的健康计划。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票，胜过 Teladoc Health</li>
<li>AAPL：忘掉 iPhone——服务将推动下一个增长阶段</li>
<li>Ackman 和 Berkshire 在人工智能上相互对赌</li>
<li>你可能错过的 1320 亿美元基础设施转型</li>
<li>Nebius Group 在强劲盈利后被下调评级，股价回落 9%</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元于 Teladoc Health 吗？</h2>
<p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Teladoc Health 并不在其中。</p>
<p>虽然 Teladoc Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TDOC

FDHT

远程医疗和数字健康 ETF - GlobalX

HEAL

<p>Teladoc Health（纽约证券交易所代码：TDOC）经历了异常的期权交易，购买了 26,725 份看涨期权，比平均水平增加了 81%。首席执行官 Charles Divita III 以每股 5.49 美元出售了 27,731 股。机构投资者持有 76.82% 的股份。TDOC 股票上涨 4.6%，至 6.65 美元，市值为 12 亿美元。公司报告的季度每股收益为-0.36 美元，未达到预期，并将 2026 财年的指导目标设定为每股收益在-1.050 至-0.750 之间</p>

<p>Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) saw unusually large options trading activity on Tuesday. Traders bought 26,725 call options on the stock. This is an increase of 81% compared to the average daily volume of 14,793 call options.</p>
<div class="lb-trans"><p>Teladoc Health, Inc.（纽约证券交易所代码：TDOC - 获取免费报告）在周二的期权交易活动中出现了异常大的交易量。交易者购买了 26,725 份看涨期权。这比平均每日交易量 14,793 份看涨期权增加了 81%。</p>
</div><p>Get <strong>Teladoc Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Teladoc Health</strong> 的提醒：</p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><ul>
<li>Peloton Stock Is Rallying, But Can It Deliver Another 70% Upside?</li>
</ul>
<div class="lb-trans"><ul>
<li>Peloton 股票正在上涨，但它能否再提供 70% 的上涨空间？</li>
</ul>
</div><p>In other Teladoc Health news, CEO Charles Divita III sold 27,731 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the completion of the sale, the chief executive officer directly owned 364,784 shares of the company's stock, valued at $2,002,664.16. The trade was a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.70% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Teladoc Health 的新闻中，首席执行官 Charles Divita III 于 3 月 11 日（星期三）出售了 27,731 股公司的股票。股票以平均价格 5.49 美元出售，总价值为 152,243.19 美元。出售完成后，首席执行官直接持有 364,784 股公司的股票，价值为 2,002,664.16 美元。此次交易使其持股减少了 7.06%。该交易在向美国证券交易委员会的法律文件中披露，文件可通过此链接获取。公司内部人士持有 0.70% 的股票。</p>
</div><h2>Institutional Trading of Teladoc Health</h2>
<div class="lb-trans"><h2>Teladoc Health 的机构交易</h2>
</div><p>A number of large investors have recently made changes to their positions in TDOC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Teladoc Health by 2.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider's stock valued at $1,542,000 after buying an additional 5,235 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Teladoc Health by 1,278.7% in the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider's stock valued at $90,000 after buying an additional 10,485 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Teladoc Health by 5.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider's stock worth $3,566,000 after purchasing an additional 24,124 shares in the last quarter. Acadian Asset Management LLC bought a new position in Teladoc Health during the 1st quarter worth about $615,000. Finally, Envestnet Asset Management Inc. bought a new position in Teladoc Health during the 2nd quarter worth about $89,000. Institutional investors own 76.82% of the company's stock.</p>
<div class="lb-trans"><p>一些大型投资者最近对 TDOC 的持仓进行了调整。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 Teladoc Health 的持仓增加了 2.8%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前持有 193,714 股该健康服务提供商的股票，价值为 1,542,000 美元，此前在上个季度又购买了 5,235 股。NewEdge Advisors LLC 在第一季度将其在 Teladoc Health 的持仓增加了 1,278.7%。NewEdge Advisors LLC 目前持有 11,305 股该健康服务提供商的股票，价值为 90,000 美元，此前在上个季度又购买了 10,485 股。瑞银资产管理公司（UBS AM）旗下的一个独立业务单位在第一季度将其在 Teladoc Health 的持仓增加了 5.7%。瑞银资产管理公司（UBS AM）目前持有 447,992 股该健康服务提供商的股票，价值为 3,566,000 美元，此前在上个季度又购买了 24,124 股。Acadian Asset Management LLC 在第一季度购买了 Teladoc Health 的新头寸，价值约为 615,000 美元。最后，Envestnet Asset Management Inc. 在第二季度购买了 Teladoc Health 的新头寸，价值约为 89,000 美元。机构投资者持有公司 76.82% 的股票。</p>
</div><h2>Teladoc Health Trading Up 4.6%</h2>
<div class="lb-trans"><h2>Teladoc Health 股票上涨 4.6%</h2>
</div><ul>
<li>2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只可能受益于特朗普新任 FDA 官员的远程医疗股票</li>
</ul>
</div><p>Shares of TDOC stock traded up $0.30 during trading hours on Tuesday, reaching $6.65. The company had a trading volume of 1,912,227 shares, compared to its average volume of 5,878,010. The company has a 50 day moving average of $5.75 and a 200 day moving average of $6.29. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. The firm has a market cap of $1.20 billion, a price-to-earnings ratio of -6.83 and a beta of 2.08. Teladoc Health has a 1-year low of $4.40 and a 1-year high of $9.77.</p>
<div class="lb-trans"><p>周二，TDOC 股票在交易时段上涨了 0.30 美元，达到 6.65 美元。该公司的交易量为 1,912,227 股，而其平均交易量为 5,878,010 股。该公司的 50 日移动平均线为 5.75 美元，200 日移动平均线为 6.29 美元。公司的债务与股本比率为 0.75，流动比率为 2.80，速动比率为 2.72。该公司的市值为 12 亿美元，市盈率为-6.83，贝塔值为 2.08。Teladoc Health 的一年低点为 4.40 美元，一年高点为 9.77 美元。</p>
</div><p>Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The company had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. During the same period last year, the company earned ($0.53) EPS. The business's revenue for the quarter was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050--0.750 EPS and its Q2 2026 guidance at -0.300--0.200 EPS. On average, equities research analysts anticipate that Teladoc Health will post -0.92 EPS for the current year.</p>
<div class="lb-trans"><p>Teladoc Health（纽约证券交易所代码：TDOC - 获取免费报告）最近于 4 月 29 日（星期三）发布了季度财报。该健康服务提供商报告每股收益为（0.36 美元），低于分析师一致预期的（0.35 美元），差距为（0.01 美元）。Teladoc Health 的净利润率为-6.81%，股本回报率为-11.45%。该公司在本季度的收入为 6.1385 亿美元，而分析师预期为 6.1104 亿美元。去年同期，该公司每股收益为（0.53 美元）。该公司的季度收入较去年同期下降了 2.5%。Teladoc Health 将其 2026 财年的指导目标设定为每股收益-1.050 至-0.750 美元，2026 年第二季度的指导目标为每股收益-0.300 至-0.200 美元。平均而言，股票研究分析师预计 Teladoc Health 在当前年度的每股收益为-0.92 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只曾经的疫情明星股票瞄准 2025 年的大反弹</li>
</ul>
</div><p>A number of brokerages have weighed in on TDOC. Barclays reduced their price target on Teladoc Health from $8.50 to $7.00 and set an &#34;equal weight&#34; rating for the company in a research report on Thursday, March 26th. BMO Capital Markets lowered their price target on Teladoc Health from $8.00 to $5.00 and set a &#34;market perform&#34; rating on the stock in a research note on Thursday, February 26th. Weiss Ratings reaffirmed a &#34;sell (e+)&#34; rating on shares of Teladoc Health in a report on Friday, March 27th. Citigroup increased their price target on Teladoc Health from $6.00 to $7.00 and gave the stock a &#34;neutral&#34; rating in a research report on Tuesday, May 5th. Finally, Leerink Partners reduced their price objective on Teladoc Health from $8.50 to $5.50 and set a &#34;market perform&#34; rating on the stock in a report on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of &#34;Hold&#34; and an average target price of $7.53.</p>
<div class="lb-trans"><p>一些券商对 TDOC 进行了评估。巴克莱在 3 月 26 日的研究报告中将 Teladoc Health 的目标价从 8.50 美元下调至 7.00 美元，并对该公司给予了 “持平” 评级。BMO Capital Markets 在 2 月 26 日的研究报告中将 Teladoc Health 的目标价从 8.00 美元下调至 5.00 美元，并对该股票给予了 “市场表现” 评级。Weiss Ratings 在 3 月 27 日的报告中重申了对 Teladoc Health 股票的 “卖出（e+）” 评级。花旗集团在 5 月 5 日的研究报告中将 Teladoc Health 的目标价从 6.00 美元上调至 7.00 美元，并对该股票给予了 “中性” 评级。最后，Leerink Partners 在 2 月 26 日的报告中将 Teladoc Health 的目标价从 8.50 美元下调至 5.50 美元，并对该股票给予了 “市场表现” 评级。五位研究分析师对该股票给予了买入评级，十二位给予了持有评级，一位给予了卖出评级。根据 MarketBeat，该公司目前的平均评级为 “持有”，平均目标价为 7.53 美元。</p>
</div><p><strong>Get Our Latest Analysis on TDOC</strong></p>
<div class="lb-trans"><p><strong>获取我们对 TDOC 的最新分析</strong></p>
</div><h2>Teladoc Health Company Profile</h2>
<div class="lb-trans"><h2>Teladoc Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.</p>
<div class="lb-trans"><p>Teladoc Health, Inc 是全球领先的虚拟医疗服务提供商，通过电话、视频和移动应用平台提供按需医疗咨询。该公司将患者与持牌医生和专家连接，以解决非紧急医疗问题、心理健康支持、皮肤病和慢性病管理。通过利用数字技术和数据分析，Teladoc 旨在提高可及性、降低医疗成本，并通过个性化护理计划和远程监测改善患者结果。</p>
</div><p>Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.</p>
<div class="lb-trans"><p>Teladoc 的服务组合包括普通医疗访问、行为健康会话、复杂病例的专家医疗服务，以及旨在支持慢性病管理（如糖尿病、高血压和心脏病）的健康计划。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Teladoc Health</li>
<li>AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth</li>
<li>Ackman and Berkshire Are Betting Against Each Other on AI</li>
<li>The $132 Billion Infrastructure Pivot You Might Have Missed</li>
<li>Nebius Group Pulls Back 9% After a Downgrade Despite Strong Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Teladoc Health</li>
<li>AAPL：忘掉 iPhone——服务将推动下一个增长阶段</li>
<li>Ackman 和 Berkshire 在人工智能上相互对赌</li>
<li>你可能错过的 1320 亿美元基础设施转型</li>
<li>Nebius Group 在强劲盈利后被下调评级，股价回落 9%</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Teladoc Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元于 Teladoc Health 吗？</h2>
</div><p>Before you consider Teladoc Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Teladoc Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，而 Teladoc Health 并不在其中。</p>
</div><p>While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Teladoc Health 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Market Beat

Teladoc

Fidelity Digital Health ETF

Global X HealthTech ETF

Peloton Interactive

瑞银集团

Arcadian Asset

巴克莱银行

蒙特利尔银行

花旗

CITIGROUP INC 6.250 NON CUM SER II PFD WI

Teladoc Health 成为异常大规模期权交易的目标（纽约证券交易所代码：TDOC）